Filter your results
- 2
- 2
- 4
- 4
- 2
- 2
- 4
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern FranceEBioMedicine, 2021, 70, pp.103495. ⟨10.1016/j.ebiom.2021.103495⟩
Journal articles
hal-03591559v1
|
||
|
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infectionMed, 2022, 3 (12), pp.838-847.e3. ⟨10.1016/j.medj.2022.09.010⟩
Journal articles
pasteur-04082610v1
|
||
|
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodiesNature Medicine, 2021, ⟨10.1038/s41591-021-01318-5⟩
Journal articles
pasteur-03207907v1
|
||
|
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cellsNature Communications, 2022, 13 (1), pp.630. ⟨10.1038/s41467-022-28307-7⟩
Journal articles
pasteur-03654220v1
|